Description: This is a panel discussion session examining the future of individual comprehensive medical expense insurance including trends, state regulation, plan design, and financial experience. From Record Of The Society Of Actuaries Volume 8, Number 4

Description: Social Insurance & Public Finance Section council members provide a recap of sessions from the 2021 SOA Health Meeting, with a focus on sessions covering Medicare, Medicaid, the ACA, and public policy. The authors include a description of SIPF Section-sponsored sections, including a session on the ACA and a session on CMS's Direct Contracting Model.

Description: Panelists at this session of the SOA 1995 Vancouver Spring Meeting discuss the financial implications of managed care for health insurance profitability. Factors that affect profitability for managed care companies and health insurance companies are discussed.

Description: What is the difference between a Single-Payer and Universal Health Care System, and how could the U.S. implement a system that would reduce the growth of medical costs while increasing quality.

Description: New technologies have created alternative treatments to improve vision and hearing. What are these technologies and their cost? Can these procedures be insured? What is the cost impact if covered? From the Record of the Society of Actuaries, Vol. 31, No. 2, Session 86

Description: This paper suggests that many problems in health insurance pricing can be solved by requiring a minimum mandatory paid-up period [i.e., premium period shorter than insurance period], and by encouraging insureds to persist by providing them adequate pricing information. This will generate significant investment income for insuring programs and reduce the cost of insurance.

Description: This 1980 session is about effect of government actions and consumerism on product design and pricing. Areas addressed: 1. What have been the most important regulatory and consumerist actions in the past decade as related to products, their marketing and the overall operation of a life insurance company? 2. What will be the most important actions in these arenas in the next decade? 3. What specific impact have these regulatory and consumer actions had on companies in the past decade and will they have in the coming decade? 4. What true value has accrued to consumers and the public because of these actions, and what impact will they have in the next decade? 5. Is there an acceptable relationship between the value of these benefits and the cost to the companies of providing them?

Description: Panelists provide their perspectives on current issues in the dental market, such as: · Product development · Experience trends · Competitive marketplace · Future outlook From the Record of the Society of Actuaries, Volume 27, No. 1, Session 65

Description: Risk adjustment is used to adjust the revenue stream to health insurers that sell ACA eligible plans and Medicare Advantage plans. This article compares and contrasts these risk adjustment programs.

Description: Introduction to additional actuarial research into development of and regulatory impact, economic impact and consumer impact of prescription drugs in the United States. Intended to further educate actuaries and others who work in this area and motivate more actuarial involvement to increase transparency, increase competition, better align stakeholder incentives and better mitigate total cost of care increases